CompletedNot Applicable

Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions

United States17 participantsStarted 2014-01-29

Plain-language summary

The purpose of this study is to determine the clinical efficacy of the application of bone marrow aspirate concentrate (BMAC) as a supplement to microfracture in the treatment of osteochondral lesions of the talus (OLTs).

Who can participate

Age range18 Years – 95 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * over age 18 * has an OLT that has not had previous surgical treatment Exclusion Criteria: * OLT greater than 1.5cm in diameter (these require more extensive treatment) * more than one OLT * radiographic evidence of widespread ankle joint arthritis * any systemic inflammatory disease * any ankle deformity

What they're measuring

Change in Pain Assessment

Timeframe: pre-operative up to 2yrs post surgery

Change in Functional Assessment

Timeframe: pre-operative to 2yrs post surgery

Trial details

NCT IDNCT02011295

SponsorDuke University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06-26

View on ClinicalTrials.gov More Osteochondral Lesions of Talus trials